Your search returned 22 results.

Results
	21.	Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway. [electronic resource] by Kondo, K Shaim, H Thompson, P A Burger, J A Keating, M Estrov, Z Harris, D Kim, E Ferrajoli, A Daher, M Basar, R Muftuoglu, M Imahashi, N Alsuliman, A Sobieski, C Gokdemir, E Wierda, W Jain, N Liu, E Shpall, E J Rezvani, K Producer: 20190219 In: Leukemia vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	22.	Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity. [electronic resource] by Liu, E Tong, Y Dotti, G Shaim, H Savoldo, B Mukherjee, M Orange, J Wan, X Lu, X Reynolds, A Gagea, M Banerjee, P Cai, R Bdaiwi, M H Basar, R Muftuoglu, M Li, L Marin, D Wierda, W Keating, M Champlin, R Shpall, E Rezvani, K Producer: 20190102 In: Leukemia vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search